首页 > 最新文献

International journal of pediatric otorhinolaryngology最新文献

英文 中文
Blood eosinophil percentage as a triage signal in pediatric allergic Rhinitis: Data-Driven cut-offs from a public cohort 血液嗜酸性粒细胞百分比作为儿科变应性鼻炎的分诊信号:来自公众队列的数据驱动切断
IF 1.3 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-12 DOI: 10.1016/j.ijporl.2025.112677
Xiaoxiao Huang , Jun Chen , Tong Wu , Chi Wang , Bo Ning , Lijuan Yang

Background

Clinicians need simple, clinic-ready rules to sort children with allergic rhinitis (AR) by near-term symptom burden. We examined whether peripheral blood eosinophil percentage (Eos %) yields useable thresholds for first-pass triage.

Methods

We performed a cross-sectional secondary analysis of a public pediatric dataset, including children with AR and non-missing Eos % and Total Nasal Symptom Score (TNSS). “High burden” was prespecified as TNSS ≥21 (cohort upper quartile). We estimated ROC/AUC, derived the Youden cut-off with 1000-bootstrap CIs, and identified targeted operating points emphasizing high sensitivity (≥0.80) or high specificity (≥0.80). Clinical utility was assessed using decision curve analysis (DCA) for threshold probabilities 0.15–0.30. Sensitivity analyses varied the TNSS cut-point and stratified by sex.

Results

Among 199 children, 26.6 % met the high-burden definition. Eos % discrimination was modest (AUC 0.606; 95 % CI 0.518–0.699). The Youden cut-off was 6.8 % (95 % CI 2.8–9.1), yielding sensitivity 0.53 and specificity 0.68 (accuracy 0.64; PPV 0.37; NPV 0.80). A ∼3.7 % rule achieved sensitivity 0.81/specificity 0.33, whereas an ∼8.5 % rule achieved specificity 0.81/sensitivity 0.32. DCA supported fixed rules in the 6–8 % band compared with treat-all/none for pt = 0.15–0.30. Findings were directionally consistent using TNSS ≥20 or ≥22 and across sex strata (boys: AUC 0.569, optimal 6.8 %; girls: AUC 0.691, optimal 3.1 %).

Conclusions

Eosinophil percentage (Eos %) exhibited modest discriminatory ability (AUC 0.606; 95 % CI 0.518–0.699) for triage in pediatric allergic rhinitis. Low thresholds of ∼3–4 % for screening, 6–8 % for balanced triage (optimal ∼6.8 %), and ∼8–9 % for confirmation offered limited utility when combined with symptom assessments. Due to weak performance, CI proximity to 0.5, and false-positive risk (e.g., PPV 0.37 at optimal cutoff), Eos % is inadequate alone and serves only as a weak complementary signal; prospective validation is essential.
临床医生需要简单的、临床准备好的规则来根据近期症状负担对过敏性鼻炎(AR)儿童进行分类。我们检查了外周血嗜酸性粒细胞百分比(Eos %)是否产生可用于第一次分流的阈值。方法:我们对公共儿科数据集进行了横断面二次分析,包括AR和未缺失的Eos %儿童和总鼻症状评分(TNSS)。“高负担”预先定义为TNSS≥21(队列上四分位数)。我们估计了ROC/AUC,用1000个bootstrap CIs导出了Youden cut-off,并确定了强调高灵敏度(≥0.80)或高特异性(≥0.80)的目标操作点。使用决策曲线分析(DCA)评估阈值概率为0.15-0.30的临床效用。敏感性分析改变了TNSS切点并按性别分层。结果199名儿童中,26.6%符合高负担定义。Eos %的歧视是中等的(AUC 0.606; 95% CI 0.518-0.699)。约登临界值为6.8% (95% CI 2.8-9.1),敏感性0.53,特异性0.68(准确性0.64;PPV 0.37; NPV 0.80)。~ 3.7%的规则达到敏感性0.81/特异性0.33,而~ 8.5%的规则达到特异性0.81/敏感性0.32。与pt = 0.15-0.30的全部治疗/不治疗相比,DCA在6 - 8%的范围内支持固定规则。当TNSS≥20或≥22以及跨性别时,结果方向一致(男孩:AUC 0.569,最优6.8%;女孩:AUC 0.691,最优3.1%)。结论嗜酸性粒细胞百分比(Eos %)对小儿变应性鼻炎的分诊具有一定的鉴别能力(AUC 0.606; 95% CI 0.518-0.699)。筛查的低阈值为~ 3 - 4%,平衡分诊的低阈值为~ 6 - 8%(最佳的~ 6.8%),确诊的低阈值为~ 8 - 9%,与症状评估结合使用时效用有限。由于性能较弱,CI接近0.5,假阳性风险(例如,最佳截止时PPV为0.37),Eos %单独是不够的,仅作为弱互补信号;前瞻性验证是必不可少的。
{"title":"Blood eosinophil percentage as a triage signal in pediatric allergic Rhinitis: Data-Driven cut-offs from a public cohort","authors":"Xiaoxiao Huang ,&nbsp;Jun Chen ,&nbsp;Tong Wu ,&nbsp;Chi Wang ,&nbsp;Bo Ning ,&nbsp;Lijuan Yang","doi":"10.1016/j.ijporl.2025.112677","DOIUrl":"10.1016/j.ijporl.2025.112677","url":null,"abstract":"<div><h3>Background</h3><div>Clinicians need simple, clinic-ready rules to sort children with allergic rhinitis (AR) by near-term symptom burden. We examined whether peripheral blood eosinophil percentage (Eos %) yields useable thresholds for first-pass triage.</div></div><div><h3>Methods</h3><div>We performed a cross-sectional secondary analysis of a public pediatric dataset, including children with AR and non-missing Eos % and Total Nasal Symptom Score (TNSS). “High burden” was prespecified as TNSS ≥21 (cohort upper quartile). We estimated ROC/AUC, derived the Youden cut-off with 1000-bootstrap CIs, and identified targeted operating points emphasizing high sensitivity (≥0.80) or high specificity (≥0.80). Clinical utility was assessed using decision curve analysis (DCA) for threshold probabilities 0.15–0.30. Sensitivity analyses varied the TNSS cut-point and stratified by sex.</div></div><div><h3>Results</h3><div>Among 199 children, 26.6 % met the high-burden definition. Eos % discrimination was modest (AUC 0.606; 95 % CI 0.518–0.699). The Youden cut-off was 6.8 % (95 % CI 2.8–9.1), yielding sensitivity 0.53 and specificity 0.68 (accuracy 0.64; PPV 0.37; NPV 0.80). A ∼3.7 % rule achieved sensitivity 0.81/specificity 0.33, whereas an ∼8.5 % rule achieved specificity 0.81/sensitivity 0.32. DCA supported fixed rules in the 6–8 % band compared with treat-all/none for pt = 0.15–0.30. Findings were directionally consistent using TNSS ≥20 or ≥22 and across sex strata (boys: AUC 0.569, optimal 6.8 %; girls: AUC 0.691, optimal 3.1 %).</div></div><div><h3>Conclusions</h3><div>Eosinophil percentage (Eos %) exhibited modest discriminatory ability (AUC 0.606; 95 % CI 0.518–0.699) for triage in pediatric allergic rhinitis. Low thresholds of ∼3–4 % for screening, 6–8 % for balanced triage (optimal ∼6.8 %), and ∼8–9 % for confirmation offered limited utility when combined with symptom assessments. Due to weak performance, CI proximity to 0.5, and false-positive risk (e.g., PPV 0.37 at optimal cutoff), Eos % is inadequate alone and serves only as a weak complementary signal; prospective validation is essential.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"200 ","pages":"Article 112677"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145787238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Newborn Hearing Screening to Diagnosis: A Clinical Study of 15,818 Cases 新生儿听力筛查诊断:15818例临床研究
IF 1.3 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2025-12-29 DOI: 10.1016/j.ijporl.2025.112701
Yanmin Chen M.M , Feiwei An PhD

Objective

To analyze the epidemiological characteristics, risk factors, and follow-up outcomes of neonatal hearing loss, thereby providing a basis for optimizing screening and intervention strategies.

Methods

A total of 15,818 newborns born at Shenzhen Maternity and Child Healthcare Hospital between January and December 2022 were enrolled. Initial screening was conducted using distortion product otoacoustic emissions (DPOAE). Infants who referred underwent rescreening with a combination of DPOAE and automated auditory brainstem response(AABR), and those who failed were referred for comprehensive diagnostic evaluation at 3 months of age, including auditory brainstem response(ABR), auditory steady-state response(ASSR), and acoustic immittance testing. Pass rates and loss-to-follow-up rates at each stage were analyzed, along with the characteristics and risk factors of confirmed hearing loss.

Results

Of the cohort, 15,643 newborns completed the initial screening, with a pass rate of 96.71%. Forty-six cases were confirmed with hearing loss, yielding a detection rate of 2.94 per 1,000. The pass rate for the right ear (97.93%) was significantly higher than for the left ear (97.55%) (P < 0.001). Among the diagnosed cases, hearing loss was predominantly unilateral (56.52%), mild-to-moderate in degree (73.91%), and conductive in type (50.00%). The primary risk factors identified were preterm birth (30.43%), low birth weight (17.39%), craniofacial anomalies (15.22%), and hyperbilirubinemia (13.04%). Follow-up and genetic testing were completed for 42 infants. Pathogenic variants in GJB2 or SLC26A4 genes were identified in 4 cases (9.52%). Hearing returned to normal in 10 infants (23.81%), while the hearing status of those with severe-to-profound loss remained stable. A significant difference was observed in the distribution of hearing loss between the initial diagnosis and follow-up (P < 0.05).

Conclusion

This study found a neonatal hearing loss detection rate consistent with previous reports, observed a higher screening pass rate in the right ear. The hearing loss was predominantly unilateral and mild-to-moderate, with follow-up revealing a dichotomous trend of either spontaneous recovery or persistence. This pattern highlights the necessity of enhancing follow-up management during the critical window between rescreening and diagnosis, and of formulating stratified and individualized intervention and follow-up protocols.
目的分析新生儿听力损失的流行病学特征、危险因素及随访结果,为优化筛查和干预策略提供依据。方法选取2022年1 - 12月在深圳市妇幼保健院出生的新生儿15818例。使用畸变产物耳声发射(DPOAE)进行初步筛选。接受DPOAE和自动听觉脑干反应(AABR)联合筛查的患儿在3个月大时接受综合诊断评估,包括听觉脑干反应(ABR)、听觉稳态反应(ASSR)和声阻抗测试。分析每个阶段的通过率和失踪率,以及确诊听力损失的特征和危险因素。结果15643名新生儿完成了首次筛查,通过率为96.71%。确诊听力损失46例,检出率为2.94‰。右耳通过率(97.93%)显著高于左耳通过率(97.55%)(P < 0.001)。听力损失以单侧(56.52%)、轻度至中度(73.91%)、传导性(50.00%)为主。确定的主要危险因素为早产(30.43%)、低出生体重(17.39%)、颅面异常(15.22%)和高胆红素血症(13.04%)。对42名婴儿进行了随访和基因检测。GJB2或SLC26A4基因致病性变异4例(9.52%)。10例患儿听力恢复正常(23.81%),重度至重度听力损失患儿听力状况保持稳定。初次诊断与随访听力损失分布差异有统计学意义(P < 0.05)。结论本研究发现新生儿听力损失检出率与文献报道一致,右耳筛查通过率较高。听力损失主要是单侧和轻度至中度,随访显示自发恢复或持续的两种趋势。这种模式强调了在重新筛查和诊断之间的关键窗口期加强随访管理的必要性,以及制定分层和个性化干预和随访方案的必要性。
{"title":"Newborn Hearing Screening to Diagnosis: A Clinical Study of 15,818 Cases","authors":"Yanmin Chen M.M ,&nbsp;Feiwei An PhD","doi":"10.1016/j.ijporl.2025.112701","DOIUrl":"10.1016/j.ijporl.2025.112701","url":null,"abstract":"<div><h3>Objective</h3><div>To analyze the epidemiological characteristics, risk factors, and follow-up outcomes of neonatal hearing loss, thereby providing a basis for optimizing screening and intervention strategies.</div></div><div><h3>Methods</h3><div>A total of 15,818 newborns born at Shenzhen Maternity and Child Healthcare Hospital between January and December 2022 were enrolled. Initial screening was conducted using distortion product otoacoustic emissions (DPOAE). Infants who referred underwent rescreening with a combination of DPOAE and automated auditory brainstem response(AABR), and those who failed were referred for comprehensive diagnostic evaluation at 3 months of age, including auditory brainstem response(ABR), auditory steady-state response(ASSR), and acoustic immittance testing. Pass rates and loss-to-follow-up rates at each stage were analyzed, along with the characteristics and risk factors of confirmed hearing loss.</div></div><div><h3>Results</h3><div>Of the cohort, 15,643 newborns completed the initial screening, with a pass rate of 96.71%. Forty-six cases were confirmed with hearing loss, yielding a detection rate of 2.94 per 1,000. The pass rate for the right ear (97.93%) was significantly higher than for the left ear (97.55%) (P &lt; 0.001). Among the diagnosed cases, hearing loss was predominantly unilateral (56.52%), mild-to-moderate in degree (73.91%), and conductive in type (50.00%). The primary risk factors identified were preterm birth (30.43%), low birth weight (17.39%), craniofacial anomalies (15.22%), and hyperbilirubinemia (13.04%). Follow-up and genetic testing were completed for 42 infants. Pathogenic variants in GJB2 or SLC26A4 genes were identified in 4 cases (9.52%). Hearing returned to normal in 10 infants (23.81%), while the hearing status of those with severe-to-profound loss remained stable. A significant difference was observed in the distribution of hearing loss between the initial diagnosis and follow-up (P &lt; 0.05).</div></div><div><h3>Conclusion</h3><div>This study found a neonatal hearing loss detection rate consistent with previous reports, observed a higher screening pass rate in the right ear. The hearing loss was predominantly unilateral and mild-to-moderate, with follow-up revealing a dichotomous trend of either spontaneous recovery or persistence. This pattern highlights the necessity of enhancing follow-up management during the critical window between rescreening and diagnosis, and of formulating stratified and individualized intervention and follow-up protocols.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"201 ","pages":"Article 112701"},"PeriodicalIF":1.3,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145881804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using the gait disorientation test to measure spatial navigation in children with cochlear implants 用步态定向障碍测试测量植入人工耳蜗儿童的空间导航能力。
IF 1.3 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2025-12-01 Epub Date: 2025-11-07 DOI: 10.1016/j.ijporl.2025.112632
Emma Kingsley , Andrew Wagner , Jessie N. Patterson , Amanda Chiao , Bisma Choudhry , Jennifer Christy , Kristen L. Janky

Objectives

The vestibular system is a collection of inertial organs that allow humans, and most other organisms, to remain appropriately oriented relative to earth's gravitational forces. A growing body of literature has identified a link between vestibular dysfunction and spatial cognitive abilities in both asymptomatic older adults and adults with confirmed vestibular loss. However, vestibular loss is also common among children with cochlear implants (CCI), with as many as 50 % showing evidence of concurrent vestibular dysfunction. Yet, how vestibular loss influences spatial cognition in CCI is limited. The primary objective of this study was to determine the impact of hearing loss and combined hearing plus vestibular loss on spatial cognitive performance by administering a mobility-based test of spatial navigation, the Gait Disorientation Test (GDT), in CCI and children with normal hearing and vestibular function.

Design

This was a cross-sectional study involving 84 children: 36 children with normal hearing (CNH), 31 CCI and normal vestibular function (CCI-NV), 9 CCI and unilateral vestibular loss (CCI-UVL) and 8 CCI and bilateral vestibular loss (CCI-BVL). The Bruininks Oseretsky Test of motor proficiency, 2nd edition (BOT-2) and the video head impulse test (vHIT) were performed alongside a measure of spatial navigation, the GDT, which was determined for each child by measuring differences in gait speed between eyes open and eyes closed walking conditions.

Results

There was no significant difference in GDT scores between the CNH (1.89 s), CCI-NV (1.91 s), CCI-UVL (2.28 s), and CCI-BVL (1.52 s) groups (Kruskal Wallis, H = 0.29, p = 0.96). Gait speed during the eyes closed portion of the GDT was not significantly different between the four groups (Kruskal Wallis, H = 1.53, p = 0.68); however, CNH (5.9 s) and CCI-BVL (6.21 s) each walked significantly slower than the CCI-NV (5.09 s) in the eyes open portion of the GDT. There was however an apparent stepwise change in BOT-2 balance scores, with lower performance amongst children with CCI and vestibular loss (Kruskal Wallis, H = 37.91, p < 0.001).

Conclusions

Unlike adults with vestibular loss, these data show that children with vestibular loss do not display significantly impaired spatial navigation relative to CNH and normal vestibular function. These data are consistent with the existence of unique compensatory responses to vestibular loss occurring later in life compared to at birth or early in development.
目的:前庭系统是一个惯性器官的集合,它允许人类和大多数其他生物相对于地球引力保持适当的方向。越来越多的文献发现,在无症状的老年人和证实有前庭功能丧失的成年人中,前庭功能障碍与空间认知能力之间存在联系。然而,前庭功能丧失在植入人工耳蜗(CCI)的儿童中也很常见,多达50%的儿童显示出并发前庭功能障碍的证据。然而,前庭功能丧失对CCI患者空间认知的影响尚不清楚。本研究的主要目的是通过对CCI和听力和前庭功能正常的儿童进行基于活动能力的空间导航测试,即步态失向测试(GDT),确定听力损失和合并听力和前庭功能损失对空间认知能力的影响。设计:这是一项涉及84名儿童的横断面研究:36名儿童听力正常(CNH), 31名CCI和前庭功能正常(CCI- nv), 9名CCI和单侧前庭功能丧失(CCI- uvl), 8名CCI和双侧前庭功能丧失(CCI- bvl)。bruinink Oseretsky运动熟练度测试(BOT-2)和视频头部脉冲测试(vHIT)与空间导航测量(GDT)一起进行,GDT是通过测量每个孩子在睁眼和闭眼行走条件下的步态速度差异来确定的。结果:CNH组(1.89 s)、CCI-NV组(1.91 s)、CCI-UVL组(2.28 s)、CCI-BVL组(1.52 s) GDT评分差异无统计学意义(Kruskal Wallis, H = 0.29, p = 0.96)。四组间GDT闭眼部分的步态速度无显著差异(Kruskal Wallis, H = 1.53, p = 0.68);然而,在GDT的睁眼部分,CNH (5.9 s)和CCI-BVL (6.21 s)的行走速度均明显慢于CCI-NV (5.09 s)。然而,BOT-2平衡评分有明显的逐步变化,CCI和前庭功能丧失的儿童表现较差(Kruskal Wallis, H = 37.91, p)。结论:与前庭功能丧失的成人不同,这些数据表明,与CNH和正常前庭功能相比,前庭功能丧失的儿童没有表现出明显的空间导航功能受损。与出生时或发育早期相比,这些数据与前庭功能丧失的独特代偿反应的存在是一致的。
{"title":"Using the gait disorientation test to measure spatial navigation in children with cochlear implants","authors":"Emma Kingsley ,&nbsp;Andrew Wagner ,&nbsp;Jessie N. Patterson ,&nbsp;Amanda Chiao ,&nbsp;Bisma Choudhry ,&nbsp;Jennifer Christy ,&nbsp;Kristen L. Janky","doi":"10.1016/j.ijporl.2025.112632","DOIUrl":"10.1016/j.ijporl.2025.112632","url":null,"abstract":"<div><h3>Objectives</h3><div>The vestibular system is a collection of inertial organs that allow humans, and most other organisms, to remain appropriately oriented relative to earth's gravitational forces. A growing body of literature has identified a link between vestibular dysfunction and spatial cognitive abilities in both asymptomatic older adults and adults with confirmed vestibular loss. However, vestibular loss is also common among children with cochlear implants (CCI), with as many as 50 % showing evidence of concurrent vestibular dysfunction. Yet, how vestibular loss influences spatial cognition in CCI is limited. The primary objective of this study was to determine the impact of hearing loss and combined hearing plus vestibular loss on spatial cognitive performance by administering a mobility-based test of spatial navigation, the Gait Disorientation Test (GDT), in CCI and children with normal hearing and vestibular function.</div></div><div><h3>Design</h3><div>This was a cross-sectional study involving 84 children: 36 children with normal hearing (CNH), 31 CCI and normal vestibular function (CCI-NV), 9 CCI and unilateral vestibular loss (CCI-UVL) and 8 CCI and bilateral vestibular loss (CCI-BVL). The Bruininks Oseretsky Test of motor proficiency, 2nd edition (BOT-2) and the video head impulse test (vHIT) were performed alongside a measure of spatial navigation, the GDT, which was determined for each child by measuring differences in gait speed between eyes open and eyes closed walking conditions.</div></div><div><h3>Results</h3><div>There was no significant difference in GDT scores between the CNH (1.89 s), CCI-NV (1.91 s), CCI-UVL (2.28 s), and CCI-BVL (1.52 s) groups (Kruskal Wallis, H = 0.29, p = 0.96). Gait speed during the eyes closed portion of the GDT was not significantly different between the four groups (Kruskal Wallis, H = 1.53, p = 0.68); however, CNH (5.9 s) and CCI-BVL (6.21 s) each walked significantly slower than the CCI-NV (5.09 s) in the eyes open portion of the GDT. There was however an apparent stepwise change in BOT-2 balance scores, with lower performance amongst children with CCI and vestibular loss (Kruskal Wallis, H = 37.91, p &lt; 0.001).</div></div><div><h3>Conclusions</h3><div>Unlike adults with vestibular loss, these data show that children with vestibular loss do not display significantly impaired spatial navigation relative to CNH and normal vestibular function. These data are consistent with the existence of unique compensatory responses to vestibular loss occurring later in life compared to at birth or early in development.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"199 ","pages":"Article 112632"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145504010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Holiday letter 2025 2025年的节日信。
IF 1.3 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2025-12-01 Epub Date: 2025-11-20 DOI: 10.1016/j.ijporl.2025.112649
Joseph E. Kerschner MD (Editor-in-Chief)
{"title":"Holiday letter 2025","authors":"Joseph E. Kerschner MD (Editor-in-Chief)","doi":"10.1016/j.ijporl.2025.112649","DOIUrl":"10.1016/j.ijporl.2025.112649","url":null,"abstract":"","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"199 ","pages":"Article 112649"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145582076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric idiopathic tracheal stenosis – A scoping review of the literature and case series of an unclassified pathology 儿童特发性气管狭窄-一个未分类病理的文献和病例系列的范围审查。
IF 1.3 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2025-12-01 Epub Date: 2025-11-01 DOI: 10.1016/j.ijporl.2025.112617
Daniel G. Eyassu , Natasha S. Lee , Hawa M. Ali , Cody L. Messick , Katerina J. Green , Joshua P. Wiedermann

Introduction

Pediatric tracheal stenosis is commonly caused by congenital or iatrogenic etiologies. This study introduces pediatric idiopathic tracheal stenosis (PITS) to refer to a cohort of pediatric patients with idiopathic multilevel large airway stenosis. This study proposes a novel treatment strategy trialed in four patients and reviews the literature for similar disease patterns.

Methods

A literature search was conducted including studies of patients under 18-years-old with tracheal stenosis of unknown etiology, yielding 6 included studies. We contribute four patients treated with CO2 laser wedge excision of tracheal scar, mitomycin C application, and triamcinolone injection followed by postoperative triple therapy with omeprazole, trimethoprim-sulfamethoxazole and inhaled fluticasone.

Results

A review of literature found seven similar cases, with high recurrence rates and no consensus on management strategies. In our case series, four pediatric patients (ages 9–14) with refractory idiopathic tracheal stenosis presented with chronic respiratory symptoms. All patients had multilevel spiral tracheal scarring with involvement of the carina and eosinophils in mucosal biopsies. Work-ups for infectious, immune, or genetic causes were uniformly negative. Initial treatments, including medical therapy and balloon dilations, failed. Definitive management with our proposed regimen led to sustained symptom remission in all cases (6 months–2.75 years).

Conclusions

PITS is sparsely described in the literature with no existing treatment consensus. We propose a novel treatment regimen that demonstrated remission of disease in this limited case series. The exploration of treatment regimens is a priority in furthering the outcomes for pediatric patients with this unique and rare airway disease.
儿童气管狭窄通常由先天性或医源性病因引起。本研究引入儿童特发性气管狭窄(PITS),指的是一组特发性多节段大气道狭窄的儿童患者。本研究提出了一种新的治疗策略,在四名患者中进行了试验,并回顾了类似疾病模式的文献。方法:检索文献,纳入病因不明的18岁以下气管狭窄患者的研究,共纳入6项研究。4例患者采用CO2激光楔形切除气管瘢痕,应用丝裂霉素C,注射曲安奈德,术后给予奥美拉唑、甲氧苄氨嘧啶-磺胺甲恶唑和吸入氟替卡松三联治疗。结果:回顾文献发现7例类似病例,复发率高,治疗策略尚无共识。在我们的病例系列中,4例难治性特发性气管狭窄的儿童患者(9-14岁)表现为慢性呼吸道症状。所有患者在粘膜活检中均有累及隆突和嗜酸性粒细胞的多级螺旋气管瘢痕。感染、免疫或遗传原因的检查结果均为阴性。最初的治疗,包括药物治疗和球囊扩张,都失败了。我们建议的方案最终治疗导致所有病例持续症状缓解(6个月-2.75年)。结论:文献中对pit的描述很少,没有现有的治疗共识。我们提出一种新的治疗方案,在这个有限的病例系列中证明了疾病的缓解。治疗方案的探索是促进这种独特而罕见的气道疾病患儿预后的优先事项。
{"title":"Pediatric idiopathic tracheal stenosis – A scoping review of the literature and case series of an unclassified pathology","authors":"Daniel G. Eyassu ,&nbsp;Natasha S. Lee ,&nbsp;Hawa M. Ali ,&nbsp;Cody L. Messick ,&nbsp;Katerina J. Green ,&nbsp;Joshua P. Wiedermann","doi":"10.1016/j.ijporl.2025.112617","DOIUrl":"10.1016/j.ijporl.2025.112617","url":null,"abstract":"<div><h3>Introduction</h3><div>Pediatric tracheal stenosis is commonly caused by congenital or iatrogenic etiologies. This study introduces pediatric idiopathic tracheal stenosis (PITS) to refer to a cohort of pediatric patients with idiopathic multilevel large airway stenosis. This study proposes a novel treatment strategy trialed in four patients and reviews the literature for similar disease patterns.</div></div><div><h3>Methods</h3><div>A literature search was conducted including studies of patients under 18-years-old with tracheal stenosis of unknown etiology, yielding 6 included studies. We contribute four patients treated with CO2 laser wedge excision of tracheal scar, mitomycin C application, and triamcinolone injection followed by postoperative triple therapy with omeprazole, trimethoprim-sulfamethoxazole and inhaled fluticasone.</div></div><div><h3>Results</h3><div>A review of literature found seven similar cases, with high recurrence rates and no consensus on management strategies. In our case series, four pediatric patients (ages 9–14) with refractory idiopathic tracheal stenosis presented with chronic respiratory symptoms. All patients had multilevel spiral tracheal scarring with involvement of the carina and eosinophils in mucosal biopsies. Work-ups for infectious, immune, or genetic causes were uniformly negative. Initial treatments, including medical therapy and balloon dilations, failed. Definitive management with our proposed regimen led to sustained symptom remission in all cases (6 months–2.75 years).</div></div><div><h3>Conclusions</h3><div>PITS is sparsely described in the literature with no existing treatment consensus. We propose a novel treatment regimen that demonstrated remission of disease in this limited case series. The exploration of treatment regimens is a priority in furthering the outcomes for pediatric patients with this unique and rare airway disease.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"199 ","pages":"Article 112617"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145451754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between MRI brain abnormalities with post-implant auditory and speech outcomes among paediatric cochlear implant candidates 在儿童人工耳蜗患者中,MRI脑异常与植入后听觉和言语预后之间的关系
IF 1.3 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-24 DOI: 10.1016/j.ijporl.2025.112559
Muhammad Hazim Azizul , Chai Jia Ning , Erica Yee Hing , Chong Chia Yin , Goh Bee See , Asma Abdullah , Wan Fazlina Wan Hashim , Norazlin Kamal Nor , Faizah Mohd Zaki
{"title":"Association between MRI brain abnormalities with post-implant auditory and speech outcomes among paediatric cochlear implant candidates","authors":"Muhammad Hazim Azizul ,&nbsp;Chai Jia Ning ,&nbsp;Erica Yee Hing ,&nbsp;Chong Chia Yin ,&nbsp;Goh Bee See ,&nbsp;Asma Abdullah ,&nbsp;Wan Fazlina Wan Hashim ,&nbsp;Norazlin Kamal Nor ,&nbsp;Faizah Mohd Zaki","doi":"10.1016/j.ijporl.2025.112559","DOIUrl":"10.1016/j.ijporl.2025.112559","url":null,"abstract":"","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"199 ","pages":"Article 112559"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145464310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterizing the spectrum and clinical impact of GJB2 mutations in patients with hearing loss: Insights into genetic variability and phenotypic outcomes 表征听力损失患者GJB2突变的频谱和临床影响:对遗传变异性和表型结果的见解
IF 1.3 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2025-12-01 Epub Date: 2025-11-04 DOI: 10.1016/j.ijporl.2025.112634
Elaheh Akhbari , Rahil Salehi , Majid Tafrihi , Reza Jafarzadeh Esfehani

Objective

This study analyzed GJB2 (connexin 26) mutations and their association with hearing loss severity in Iranian nonsyndromic hearing loss (NSHL) patients, addressing a prevalent genetic cause of hearing impairment worldwide.

Methods

This research was conducted on a cohort of individuals referred for genetic counseling for hearing loss, as well as asymptomatic individuals with a family history of NSHL. Participants were included based on confirmed diagnoses of hearing impairment without syndromic features or environmental causes. Every individual was analyzed for GJB2 mutations using sanger sequencing method. Hearing impairment was classified into four categories—mild, moderate, severe, and profound—based on pure-tone audiometry.

Results

In a cohort of 282 participants, the c.35delG mutation was the most frequent variant, present in 54.5 % of individuals with hearing impairment. This mutation was found in 12 homozygous cases, 6 heterozygotes, and 1 compound heterozygote, with a strong association with profound hearing impairment (p < 0.01). The c.487A > G variant was the second most common, identified in 14 patients and significantly correlated with severe-to-profound hearing loss (p < 0.05). Less frequent variants, including c.71G > A, c.88A > G, and c.193T > A, exhibited diverse clinical presentations, ranging from mild to profound impairment. Two compound heterozygous cases also highlighted the combined effects of multiple mutations, with both cases presenting with profound hearing loss.

Conclusion

This study underscores the significant role of GJB2 mutations, particularly c.35delG and c.487A > G, in NSHL and their strong correlation with severe-to-profound hearing impairment in northeastern Iran. The findings highlight the need for region-specific screening programs to identify high-risk variants, guide genetic counseling, and enable early intervention. Moreover, comprehensive GJB2 sequencing within broader hearing loss gene panels is recommended to capture heterogeneous variants.
目的分析伊朗非综合征性听力损失(NSHL)患者GJB2(连接蛋白26)突变及其与听力损失严重程度的关系,探讨全球范围内普遍存在的听力障碍遗传原因。方法本研究选取了一组因听力损失而进行遗传咨询的个体,以及有NSHL家族史的无症状个体。参与者被纳入是基于没有综合征特征或环境原因的听力障碍确诊。采用sanger测序法对每个个体进行GJB2突变分析。根据纯音听力学将听力障碍分为轻度、中度、重度和深度四类。结果在282名参与者的队列中,c.35delG突变是最常见的变体,存在于54.5%的听力障碍个体中。该突变在12例纯合子、6例杂合子和1例复合杂合子中发现,与重度听力障碍有很强的相关性(p < 0.01)。c.487A >; G变异是第二常见的,在14例患者中发现,与重度至重度听力损失显著相关(p < 0.05)。不常见的变异包括c.71G > A、c.88A >; G和c.193T >; A,表现出不同的临床表现,从轻度到重度损害不等。两例复合杂合病例也突出了多重突变的综合影响,两例均表现为严重的听力损失。结论本研究强调了GJB2突变,特别是c.35delG和c.487A >; G在NSHL中的重要作用,以及它们与伊朗东北部重度至重度听力障碍的强相关性。研究结果强调需要针对特定地区的筛查项目来识别高风险变异,指导遗传咨询,并使早期干预成为可能。此外,建议在更广泛的听力损失基因面板中进行全面的GJB2测序,以捕获异质变异。
{"title":"Characterizing the spectrum and clinical impact of GJB2 mutations in patients with hearing loss: Insights into genetic variability and phenotypic outcomes","authors":"Elaheh Akhbari ,&nbsp;Rahil Salehi ,&nbsp;Majid Tafrihi ,&nbsp;Reza Jafarzadeh Esfehani","doi":"10.1016/j.ijporl.2025.112634","DOIUrl":"10.1016/j.ijporl.2025.112634","url":null,"abstract":"<div><h3>Objective</h3><div>This study analyzed GJB2 (connexin 26) mutations and their association with hearing loss severity in Iranian nonsyndromic hearing loss (NSHL) patients, addressing a prevalent genetic cause of hearing impairment worldwide.</div></div><div><h3>Methods</h3><div>This research was conducted on a cohort of individuals referred for genetic counseling for hearing loss, as well as asymptomatic individuals with a family history of NSHL. Participants were included based on confirmed diagnoses of hearing impairment without syndromic features or environmental causes. Every individual was analyzed for GJB2 mutations using sanger sequencing method. Hearing impairment was classified into four categories—mild, moderate, severe, and profound—based on pure-tone audiometry.</div></div><div><h3>Results</h3><div>In a cohort of 282 participants, the c.35delG mutation was the most frequent variant, present in 54.5 % of individuals with hearing impairment. This mutation was found in 12 homozygous cases, 6 heterozygotes, and 1 compound heterozygote, with a strong association with profound hearing impairment (p &lt; 0.01). The c.487A &gt; G variant was the second most common, identified in 14 patients and significantly correlated with severe-to-profound hearing loss (p &lt; 0.05). Less frequent variants, including c.71G &gt; A, c.88A &gt; G, and c.193T &gt; A, exhibited diverse clinical presentations, ranging from mild to profound impairment. Two compound heterozygous cases also highlighted the combined effects of multiple mutations, with both cases presenting with profound hearing loss.</div></div><div><h3>Conclusion</h3><div>This study underscores the significant role of GJB2 mutations, particularly c.35delG and c.487A &gt; G, in NSHL and their strong correlation with severe-to-profound hearing impairment in northeastern Iran. The findings highlight the need for region-specific screening programs to identify high-risk variants, guide genetic counseling, and enable early intervention. Moreover, comprehensive <em>GJB2</em> sequencing within broader hearing loss gene panels is recommended to capture heterogeneous variants.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"199 ","pages":"Article 112634"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145464312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Universal newborn hearing screening in Kuwait: Outcomes and implications for national implementation 科威特新生儿普遍听力筛查:结果和对国家实施的影响。
IF 1.3 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-31 DOI: 10.1016/j.ijporl.2025.112629
Aseel Almeqbel
{"title":"Universal newborn hearing screening in Kuwait: Outcomes and implications for national implementation","authors":"Aseel Almeqbel","doi":"10.1016/j.ijporl.2025.112629","DOIUrl":"10.1016/j.ijporl.2025.112629","url":null,"abstract":"","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"199 ","pages":"Article 112629"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145458623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fear of missing out (FoMO) and smartphone addiction among adolescents using cochlear implants and hearing aids: A cross-sectional assessment 使用人工耳蜗和助听器的青少年的错失恐惧(FoMO)和智能手机成瘾:一项横断面评估。
IF 1.3 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-31 DOI: 10.1016/j.ijporl.2025.112631
Emre Söylemez , Yusuf Oktay Atılgan , Cihangir Karakaya , Mehmet Başcıllar , Ferhat Toper , Serdar Ensari

Objective

The aim of this study is to examine the levels of smartphone addiction and fear of missing out (FoMO) among adolescents with hearing loss, and to analyze the relationships between these factors and social anxiety.

Methods

The study included 26 adolescents with hearing loss (SNHL group) who use hearing aids (HA) or cochlear implants (CI) and communicate through oral language, along with 26 adolescents without hearing loss (control group). The degree of hearing loss and the use of HA/CI among participants with hearing loss, as well as smartphone usage characteristics for all participants, were documented. All individuals completed the Smartphone Addiction Scale–Short Version (SAS-SV), the Social Anxiety Scale for Adolescents (SAS-A), and the Turkish version of the Fear of Missing Out Scale (T-FoMOS).

Results

Adolescents in the SNHL group had significantly higher scores on the T-FoMOS, SAS-SV, and social anxiety in novel situations subscale of the SAS-A compared to those in the control group (p < 0.05). Additionally, adolescents with SNHL reported using smartphones for gaming significantly more often than their peers without hearing loss (p = 0.025). There was a positive correlation between T-FoMOS, SAS-SV, and SAS-A scores (p < 0.05).

Conclusion

The findings suggest that children with hearing loss may differ from their peers with typical hearing in terms of their relationship with digital media and psychosocial characteristics, even when they benefit from auditory devices such as CIs or HAs. Therefore, it is important to monitor smartphone use in children with hearing loss and to provide early support for managing FoMO and social anxiety.
目的:本研究旨在调查听力损失青少年智能手机成瘾和错失恐惧(FoMO)的水平,并分析这些因素与社交焦虑的关系。方法:选取26例使用助听器(HA)或人工耳蜗(CI)进行口语交流的听力损失青少年(SNHL组)和26例无听力损失青少年(对照组)。记录了听力损失参与者的听力损失程度和HA/CI的使用情况,以及所有参与者的智能手机使用特征。所有人都完成了智能手机成瘾量表-短版(SAS-SV),青少年社交焦虑量表(SAS-A)和土耳其版的错过恐惧量表(t - fomo)。结果:与对照组相比,SNHL组的青少年在t - fmos、SAS-SV和SAS-A的新情境社交焦虑亚量表上的得分显著高于对照组(p结论:研究结果表明,听力损失儿童在与数字媒体的关系和心理社会特征方面可能与听力正常的同龄人不同,即使他们受益于诸如CIs或HAs之类的听觉设备。因此,监测听力损失儿童的智能手机使用情况,并为管理FoMO和社交焦虑提供早期支持是很重要的。
{"title":"Fear of missing out (FoMO) and smartphone addiction among adolescents using cochlear implants and hearing aids: A cross-sectional assessment","authors":"Emre Söylemez ,&nbsp;Yusuf Oktay Atılgan ,&nbsp;Cihangir Karakaya ,&nbsp;Mehmet Başcıllar ,&nbsp;Ferhat Toper ,&nbsp;Serdar Ensari","doi":"10.1016/j.ijporl.2025.112631","DOIUrl":"10.1016/j.ijporl.2025.112631","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of this study is to examine the levels of smartphone addiction and fear of missing out (FoMO) among adolescents with hearing loss, and to analyze the relationships between these factors and social anxiety.</div></div><div><h3>Methods</h3><div>The study included 26 adolescents with hearing loss (SNHL group) who use hearing aids (HA) or cochlear implants (CI) and communicate through oral language, along with 26 adolescents without hearing loss (control group). The degree of hearing loss and the use of HA/CI among participants with hearing loss, as well as smartphone usage characteristics for all participants, were documented. All individuals completed the Smartphone Addiction Scale–Short Version (SAS-SV), the Social Anxiety Scale for Adolescents (SAS-A), and the Turkish version of the Fear of Missing Out Scale (T-FoMOS).</div></div><div><h3>Results</h3><div>Adolescents in the SNHL group had significantly higher scores on the T-FoMOS, SAS-SV, and social anxiety in novel situations subscale of the SAS-A compared to those in the control group (p &lt; 0.05). Additionally, adolescents with SNHL reported using smartphones for gaming significantly more often than their peers without hearing loss (p = 0.025). There was a positive correlation between T-FoMOS, SAS-SV, and SAS-A scores (p &lt; 0.05).</div></div><div><h3>Conclusion</h3><div>The findings suggest that children with hearing loss may differ from their peers with typical hearing in terms of their relationship with digital media and psychosocial characteristics, even when they benefit from auditory devices such as CIs or HAs. Therefore, it is important to monitor smartphone use in children with hearing loss and to provide early support for managing FoMO and social anxiety.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"199 ","pages":"Article 112631"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145451809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patients with allergic rhinitis are more likely to need a secondary adenoidectomy after 6 months 过敏性鼻炎患者在6个月后更有可能需要二次腺样体切除术。
IF 1.3 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2025-12-01 Epub Date: 2025-11-11 DOI: 10.1016/j.ijporl.2025.112646
Sofia Piperno , Truman Archer , Sawyer Archer , Elizabeth McCarthy , Delaney E.S. Clark , Brian P. Quinlan , Harold Pine

Background

Adenoidectomy, without concomitant procedures like tonsillectomy, is the third most common ambulatory pediatric operation. Allergic rhinitis is a common comorbidity that is known to cause adenoid hypertrophy. With time and progression, adenoid hypertrophy can become symptomatic and necessitate removal. Our aim is to assess how patients diagnosed with allergic rhinitis affect the need for a secondary adenoidectomy over time.

Methods

We queried the TriNetX database and produced the statistical analysis for this project. The control group consisted of patients who have not been diagnosed with allergic rhinitis and have undergone a primary adenoidectomy. Cohorts were balanced using native TriNetX propensity matching before analysis. Outcomes measured included the presence of secondary adenoidectomy after 0–0.5, 0.5–1, 1–2, 2–3, 3–4, 4–5, 5–7, and 7+ years of primary adenoidectomy.

Results

65,106 patients were assessed with a mean average age of 6.36 ± 7.82 and 6.34 ± 7.71 years between the control and experimental group. There was no difference in secondary adenoidectomy occurrences between the two groups between 1 day and 0.5 years after primary adenoidectomy (p = 0.896, RR 1.632 (0.922,2.888)). There was a difference between 0.5 and 1 year (p < 0.0001), 1–2 years (p < 0.0001), 2–3 years (p < 0.0001), 3–4 years (p = 0.001), 4–5 years (p = 0.001), 5–7 years (p = 0.0002), and more than 7 years (p = 0.0023).

Conclusions

After 0.5 years of primary adenoidectomy surgery, patients diagnosed with allergic rhinitis are more likely to need a secondary adenoidectomy compared to their counterparts not diagnosed with allergic rhinitis.
背景:腺样体切除术是第三种最常见的儿科门诊手术,不伴有扁桃体切除术。过敏性鼻炎是一种常见的共病,已知可引起腺样体肥大。随着时间的推移和进展,腺样体肥大可能成为症状,需要切除。我们的目的是评估诊断为过敏性鼻炎的患者如何随着时间的推移影响二次腺样体切除术的需要。方法:查询TriNetX数据库,对该项目进行统计分析。对照组由未被诊断为过敏性鼻炎且接受过原发性腺样体切除术的患者组成。在分析之前,使用原生TriNetX倾向匹配来平衡队列。测量的结果包括原发性腺样体切除术后0-0.5、0.5-1、1-2、2-3、3-4、4-5、5-7和7年以上的继发腺样体切除术。结果:共纳入65,106例患者,对照组和实验组的平均年龄分别为6.36±7.82岁和6.34±7.71岁。两组患者在原发性腺样体切除术后1天和0.5年内继发腺样体切除术发生率无差异(p = 0.896, RR 1.632(0.922,2.888))。结论:在原发腺样体切除手术0.5年后,诊断为变应性鼻炎的患者比未诊断为变应性鼻炎的患者更有可能需要二次腺样体切除术。
{"title":"Patients with allergic rhinitis are more likely to need a secondary adenoidectomy after 6 months","authors":"Sofia Piperno ,&nbsp;Truman Archer ,&nbsp;Sawyer Archer ,&nbsp;Elizabeth McCarthy ,&nbsp;Delaney E.S. Clark ,&nbsp;Brian P. Quinlan ,&nbsp;Harold Pine","doi":"10.1016/j.ijporl.2025.112646","DOIUrl":"10.1016/j.ijporl.2025.112646","url":null,"abstract":"<div><h3>Background</h3><div>Adenoidectomy, without concomitant procedures like tonsillectomy, is the third most common ambulatory pediatric operation. Allergic rhinitis is a common comorbidity that is known to cause adenoid hypertrophy. With time and progression, adenoid hypertrophy can become symptomatic and necessitate removal. Our aim is to assess how patients diagnosed with allergic rhinitis affect the need for a secondary adenoidectomy over time.</div></div><div><h3>Methods</h3><div>We queried the TriNetX database and produced the statistical analysis for this project. The control group consisted of patients who have not been diagnosed with allergic rhinitis and have undergone a primary adenoidectomy. Cohorts were balanced using native TriNetX propensity matching before analysis. Outcomes measured included the presence of secondary adenoidectomy after 0–0.5, 0.5–1, 1–2, 2–3, 3–4, 4–5, 5–7, and 7+ years of primary adenoidectomy.</div></div><div><h3>Results</h3><div>65,106 patients were assessed with a mean average age of 6.36 ± 7.82 and 6.34 ± 7.71 years between the control and experimental group. There was no difference in secondary adenoidectomy occurrences between the two groups between 1 day and 0.5 years after primary adenoidectomy (p = 0.896, RR 1.632 (0.922,2.888)). There was a difference between 0.5 and 1 year (p &lt; 0.0001), 1–2 years (p &lt; 0.0001), 2–3 years (p &lt; 0.0001), 3–4 years (p = 0.001), 4–5 years (p = 0.001), 5–7 years (p = 0.0002), and more than 7 years (p = 0.0023).</div></div><div><h3>Conclusions</h3><div>After 0.5 years of primary adenoidectomy surgery, patients diagnosed with allergic rhinitis are more likely to need a secondary adenoidectomy compared to their counterparts not diagnosed with allergic rhinitis.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"199 ","pages":"Article 112646"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145512465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of pediatric otorhinolaryngology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1